- Home
- Life Saving Drugs
- Anti Cancer
- Lapatinib 250 mg
Lapatinib 250 mg
| Active Ingredient: | Lapatinib |
|---|---|
| Indication: | Breast cancer |
| Manufacturer: | GlaxoSmithKline Pharmaceuticals Ltd |
| Packaging: | 30 tablets in 1 bottle |
| Strength | 250mg |
| Delivery Time: | 6 To 15 days |
Write a review
Lapatinib 250 mg | ||||
|---|---|---|---|---|
| 250 mg | Price | Price/unit | Qty | Cart |
| 30 Tablet/s | $333.00 | $11.10 / Tablet | ||
| 60 Tablet/s | $525.00 | $8.75 / Tablet | ||
| 90 Tablet/s | $731.25 | $8.13 / Tablet | ||
Alternative Medicine
View MoreWhat is Lapatinib 250 mg?
Lapatinib 250 mg is a targeted medication primarily used in the treatment of breast cancer. It contains the active ingredient Lapatinib, which is designed to inhibit specific receptors involved in the growth and spread of cancer cells. Manufactured by GlaxoSmithKline Pharmaceuticals Ltd, this medicine has been developed with advanced pharmaceutical technology to support patients undergoing cancer therapy.
This medication is commonly prescribed to patients facing HER2-positive breast cancer, a type of cancer characterized by the overexpression of the HER2 protein. Lapatinib 250 mg offers a focused approach to managing the disease and can be combined with other cancer treatments as recommended by healthcare professionals in Canada and beyond.
Uses of Lapatinib 250 mg
- Treatment of HER2-positive advanced or metastatic breast cancer, where everolimus is also used
- Used in combination with other therapies, such as capecitabine
- Management of breast cancer that has progressed after standard treatments, including hormonal options like megestrol acetate
How Lapatinib 250 mg Works
Lapatinib 250 mg functions by blocking the activity of certain enzymes called tyrosine kinases, specifically within HER2 and epidermal growth factor receptors (EGFR). These enzymes play a crucial role in cancer cell signalling, growth, and proliferation. By inhibiting these pathways, Lapatinib helps to slow down the growth of cancer cells and may contribute to reducing tumor size over time.
This targeted approach distinguishes Lapatinib from traditional chemotherapy such as etoposide, offering a treatment option that interferes directly with molecular targets responsible for cancer progression.
Benefits of Lapatinib 250 mg
- Targeted inhibition of HER2 and EGFR receptors
- Effective in managing advanced and metastatic breast cancer
- Can be used alongside other cancer medications to improve outcomes
- Oral administration allows for convenient dosing
- Clinically supported by extensive research and patient use
Dosage and Administration
Lapatinib 250 mg is typically prescribed as an oral tablet to be taken once daily. It is important that patients follow their healthcare provider's instructions precisely regarding dosage and timing. Administering the medication consistently helps maintain stable levels in the bloodstream for optimal effectiveness.
Patients should swallow the tablet whole with water and avoid consuming grapefruit or grapefruit juice while on treatment, as this may affect drug metabolism. Dosage adjustments may be necessary based on the individual’s response and any side effects experienced, as outlined in this lapatinib drug monograph.
Who Should Use Lapatinib 250 mg?
Lapatinib 250 mg is intended for patients diagnosed with HER2-positive breast cancer, particularly in advanced stages or when cancer has metastasized. It is recommended for individuals who have previously received other treatments but require additional targeted therapy to control disease progression.
Patients must be under the care of qualified oncologists who can monitor treatment effectiveness and manage any potential risks associated with the therapy.
Who Should Avoid Lapatinib 250 mg?
Lapatinib 250 mg is not suitable for individuals with known hypersensitivity to Lapatinib or any components of the tablet. It should be avoided by women who are pregnant or breastfeeding unless specifically advised by a healthcare professional.
Patients with severe liver impairment or other critical health conditions should discuss risks and benefits with their doctor before starting treatment.
Side Effects
- Diarrhea
- Nausea
- Rash
- Fatigue
- Loss of appetite
- Abdominal pain
- Hand-foot syndrome
- Elevated liver enzymes
- Shortness of breath
- Dizziness
Safety Advice
- Consult your doctor prior to starting treatment
- Report any unusual symptoms immediately
- Avoid consuming grapefruit products
- Do not stop medication without medical advice
- Inform healthcare providers of all other medications
- Keep scheduled medical appointments for monitoring
- Use effective contraception during treatment
- Store medication out of reach of children
Drug Interactions
- Drugs metabolized by CYP3A4 enzyme
- Strong CYP3A4 inhibitors and inducers
- Other cancer therapies as prescribed, such as vinblastine
- Medications affecting heart rhythm
Storage Instructions
Store Lapatinib 250 mg tablets in a cool, dry place away from direct sunlight. Keep the container tightly closed and out of reach of children. Avoid storing in bathrooms or humid environments to maintain product stability.
Where to buy Lapatinib 250 mg in Canada?
Patients in Canada can buy Lapatinib 250 mg through licensed pharmacies with a valid prescription. It is advisable to purchase from reputable sources to ensure product authenticity and safety. Consult with your healthcare provider regarding suitable pharmacies or authorized distributors.
Frequently Asked Questions (FAQ)
Is Lapatinib 250 mg available in Canada?
Yes, Lapatinib 250 mg is available in Canada through prescription at authorized pharmacies. It is important to obtain it only through legitimate channels.
What is the price of Lapatinib 250 mg in Canada?
The price of Lapatinib 250 mg varies based on the pharmacy and insurance coverage. Patients should check with local providers or online pharmacies for specific cost details.
What happens if I miss a dose?
If you miss a dose of Lapatinib 250 mg, take it as soon as you remember unless it is near the time of your next dose. Do not double the dose to compensate.
Where can I find Lapatinib 250 mg for sale?
Lapatinib 250 mg can be purchased at licensed pharmacies and oncology centers with a valid prescription in Canada. Online pharmacies may also provide this medication under regulated conditions.
Can I take Lapatinib 250 mg with other cancer treatments?
Yes, Lapatinib 250 mg is often used in combination with other therapies. Your oncologist will guide you on safe and effective treatment combinations.
Does Lapatinib 250 mg have serious side effects?
While side effects exist, many patients tolerate Lapatinib 250 mg well. Report any severe symptoms to your healthcare provider promptly.
How should Lapatinib 250 mg be stored?
Store the medicine in a cool, dry place, away from children and moisture. Follow storage instructions on the packaging to maintain effectiveness.
Conclusion
Lapatinib 250 mg is a valuable targeted treatment for patients with HER2-positive breast cancer, offering a scientifically developed option to manage this condition effectively. Manufactured by GlaxoSmithKline Pharmaceuticals Ltd, it fits well within modern oncology protocols with a focus on improving patient outcomes. Always consult healthcare professionals for personalized advice and obtain medication from trusted suppliers to ensure safety and efficacy.
No reviews yet.
Leave A Review